English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated

MPS-Authors
/persons/resource/persons147294

Seidel,  Danila
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

External Resource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Krakstad, C., Birkeland, E., Seidel, D., Kusonmano, K., Petersen, K., Mjos, S., et al. (2012). High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated. PLoS ONE, 7(12): e52795. doi:10.1371/journal.pone.0052795.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0026-D565-8
Abstract
© 2012 Krakstad et al.